Health AI Central
Share:
Peer-Reviewed Publication
JMIR Res Protoc2022;11(8):e36741.August 25, 2022Journal Article

Continuous Remote Patient Monitoring in Patients With Heart Failure (Cascade Study): Protocol for a Mixed Methods Feasibility Study.

Courtney Reamer1, Wei Ning Chi2, Robert Gordon1, Nitasha Sarswat1,3, Charu Gupta1, Safwan Gaznabi1, Emily White VanGompel4, Izabella Szum5, Melissa Morton-Jost5, Jorma Vaughn6, Karen Larimer6, David Victorson7, John Erwin1,3, Lakshmi Halasyamani1,3, Anthony Solomonides2, Rema Padman8, Nirav S Shah1,3
1Department of Medicine, NorthShore University HealthSystem, Evanston, IL, United States.
2Outcomes Research Network, NorthShore University HealthSystem, Evanston, IL, United States.
3Department of Medicine, Pritzker School of Medicine, University of Chicago, Chicago, IL, United States.
4Department of Family Medicine, NorthShore University HealthSystem, Evanston, IL, United States.
5Home and Hospice Services, NorthShore University HealthSystem, Evanston, IL, United States.
6physIQ, Inc, Chicago, IL, United States.
7Department of Medical Social Sciences, Northwestern University, Evanston, IL, United States.
8Heinz College of Information Systems and Public Policy, Carnegie Mellon University, Pittsburgh, PA, United States.
PubMed PMC DOI PDF

Abstract

BACKGROUND: Heart failure (HF) is a prevalent chronic disease and is associated with increases in mortality and morbidity. HF is a leading cause of hospitalizations and readmissions in the United States. A potentially promising area for preventing HF readmissions is continuous remote patient monitoring (CRPM). OBJECTIVE: The primary aim of this study is to determine the feasibility and preliminar…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.